Nanjing Sanhome Pharmaceutical Co., Ltd.

Sanhome was founded in 1996, and aims to let more people to enjoy healthy happiness. The company has insisted on the core value of ‘customer oriented, high performance, hard working and self-criticism’, and prospects to ‘prolong people’s life expectation for 3-5 years by Sanhome’s 50th anniversary’. Furthermore, the company’s mission is to become the most trustable brand for physicians and patients. Sanhome was one of the first group of companies which have been awarded GMP certificate in China. The company has been certificated as ‘state high-tech innovation enterprise’ by China Ministry of Science & Technology in 2003, has been ranked in top 100 pharmaceutical enterprises in China since 2009, and has been awarded ‘Top 100 pharmaceutical enterprises’ and ‘Top 50 pharmaceutical enterprises in growth’ by All-China Federation of Industry & Commerce in 2015. By now, Sanhome holds more than 100 new drug certificates, 34 China invention patents and 8 oversea invention patents. Based on the company’s own technology, many chemical drugs and herb source drugs have been developed independently, including 1st class new drug (IND category), State key novel products, State protected traditional Chinese medicine products, and exclusive products in China. Meanwhile, the company is undertaking more than 20 state and provincial funded key research projects, including National high-tech R&D (863) program, National key project in new drug development, National innovation foundation project, National high-tech innovation industrialisation, China ‘torch’ program etc.